Source: International Congress 2016 – Immune responses in the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Koji Tamai (Kobe, Japan), Koji Tamai, Harukazu Yoshimatsu, Toshiharu Saito, Hirofumi Matsuoka, Yasuko Koma, Nobuhiko Okada, Akiko Otsuka, Sayaka Inoue, Sachie Kume, Nao Oda, Yujiro Suzuki. Antinuclear antibodies and rheumatoid factor are associated with blood eosinophils in asthma and COPD. Eur Respir J 2016; 48: Suppl. 60, 3634

Member's Comments

No comment yet.

Related content which might interest you: Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Autoreactivity in patients with combined COPD and asthma phenotype Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 Correlation between asthma control and serum levels of IL-33 in atopic asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Higher burden of asthma symptoms and increased blood eosinophils in ACOS Source: International Congress 2016 – Systemic biomarkers Year: 2016 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 TSLP as biomarker in asthma patients Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Increased total, secretory and NTHi-specific IgA in the COPD airway Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 IL-17A is specifically elevated in NTHi-associated AECOPD and end-stage COPD Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Mapping of eosinophil and basophils in COPD lung tissues Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Cytokine patterns and latent viruses in patients with severe asthma and COPD Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 Variability of total serum IgE in moderate-to-severe asthmatic patients Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Distribution of blood eosinophil in COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Biomarkers of obesity associated with severe atopic asthma Source: International Congress 2015 – Asthma mechanisms and management Year: 2015